Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study Assessing Long-Term Safety of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

NCT03127956 is registered in ClinicalTrials.gov with Dermira, Inc. as lead sponsor.

NCT NCT03127956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03127956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study Assessing Long-Term Safety of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Lead sponsor
Dermira, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 21, 2017
Completion date
April 27, 2018
Enrollment
748 (actual)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris